Furthermore, these studies indicated that the dysregulated expression of TLX1 did not influence disease phenotype, but rather, accelerated malignant transformation of not only T-ALL, but also AML in IgHμ-TLX1TgPrkdcScid/Scid mice. Here, TLX1 is linked to acute myeloid leukemia.